The homocystinuria market represents a highly specialized segment of rare disease therapeutics, where innovation is closely tied to advancements in genetic diagnostics and metabolic pathway research. As precision medicine evolves, the market is increasingly defined by integrated care models that combine early screening, targeted therapy, and lifelong digital monitoring. This convergence of...